Hugo_Symbol	Entrez_Gene_Id	Center	NCBI_Build	Chromosome	Start_position	End_position	Strand	Variant_Classification	Variant_Type	Reference_Allele	Tumor_Seq_Allele1	Tumor_Seq_Allele2	dbSNP_RS	dbSNP_Val_Status	Tumor_Sample_Barcode	Matched_Norm_Sample_Barcode	Match_Norm_Seq_Allele1	Match_Norm_Seq_Allele2	Tumor_Validation_Allele1	Tumor_Validation_Allele2	Match_Norm_Validation_Allele1	Match_Norm_Validation_Allele2	Verification_Status	Validation_Status	Mutation_Status	Sequencing_Phase	Sequence_Source	Validation_Method	Score	BAM_file	Sequencer	Tumor_Sample_UUID	Matched_Norm_Sample_UUID	Genome_Change	Annotation_Transcript	Transcript_Strand	Transcript_Exon	Transcript_Position	cDNA_Change	Codon_Change	Protein_Change	Other_Transcripts	Refseq_mRNA_Id	Refseq_prot_Id	SwissProt_acc_Id	SwissProt_entry_Id	Description	UniProt_AApos	UniProt_Region	UniProt_Site	UniProt_Natural_Variations	UniProt_Experimental_Info	GO_Biological_Process	GO_Cellular_Component	GO_Molecular_Function	COSMIC_overlapping_mutations	COSMIC_fusion_genes	COSMIC_tissue_types_affected	COSMIC_total_alterations_in_gene	Tumorscape_Amplification_Peaks	Tumorscape_Deletion_Peaks	TCGAscape_Amplification_Peaks	TCGAscape_Deletion_Peaks	DrugBank	ref_context	gc_content	CCLE_ONCOMAP_overlapping_mutations	CCLE_ONCOMAP_total_mutations_in_gene	CGC_Mutation_Type	CGC_Translocation_Partner	CGC_Tumor_Types_Somatic	CGC_Tumor_Types_Germline	CGC_Other_Diseases	DNARepairGenes_Role	FamilialCancerDatabase_Syndromes	MUTSIG_Published_Results	OREGANNO_ID	OREGANNO_Values	i_1000Genome_AA	i_1000Genome_AC	i_1000Genome_AF	i_1000Genome_AFR_AF	i_1000Genome_AMR_AF	i_1000Genome_AN	i_1000Genome_ASN_AF	i_1000Genome_AVGPOST	i_1000Genome_CIEND	i_1000Genome_CIPOS	i_1000Genome_END	i_1000Genome_ERATE	i_1000Genome_EUR_AF	i_1000Genome_HOMLEN	i_1000Genome_HOMSEQ	i_1000Genome_LDAF	i_1000Genome_RSQ	i_1000Genome_SNPSOURCE	i_1000Genome_SVLEN	i_1000Genome_SVTYPE	i_1000Genome_THETA	i_1000Genome_VT	i_ACHILLES_Lineage_Results_Top_Genes	i_CGC_CancerGermlineMut	i_CGC_CancerMolecularGenetics	i_CGC_CancerSomaticMut	i_CGC_CancerSyndrome	i_CGC_Chr	i_CGC_ChrBand	i_CGC_GeneID	i_CGC_Name	i_CGC_OtherGermlineMut	i_CGC_TissueType	i_COSMIC_n_overlapping_mutations	i_COSMIC_overlapping_mutation_descriptions	i_COSMIC_overlapping_primary_sites	i_ClinVar_ASSEMBLY	i_ClinVar_HGMD_ID	i_ClinVar_SYM	i_ClinVar_TYPE	i_ClinVar_rs	i_ESP_AA	i_ESP_AAC	i_ESP_AA_AC	i_ESP_AA_AGE	i_ESP_AA_GTC	i_ESP_AvgAAsampleReadDepth	i_ESP_AvgEAsampleReadDepth	i_ESP_AvgSampleReadDepth	i_ESP_CA	i_ESP_CDP	i_ESP_CG	i_ESP_CP	i_ESP_Chromosome	i_ESP_DBSNP	i_ESP_DP	i_ESP_EA_AC	i_ESP_EA_AGE	i_ESP_EA_GTC	i_ESP_EXOME_CHIP	i_ESP_FG	i_ESP_GL	i_ESP_GM	i_ESP_GS	i_ESP_GTC	i_ESP_GTS	i_ESP_GWAS_PUBMED	i_ESP_MAF	i_ESP_PH	i_ESP_PP	i_ESP_Position	i_ESP_TAC	i_ESP_TotalAAsamplesCovered	i_ESP_TotalEAsamplesCovered	i_ESP_TotalSamplesCovered	i_Ensembl_so_accession	i_Ensembl_so_term	i_Familial_Cancer_Genes_Reference	i_Familial_Cancer_Genes_Synonym	i_HGNC_EnsemblGeneID	i_HGNC_HGNCID	i_HGNC_RefSeqIDs	i_HGNC_Status	i_HGNC_UCSCIDsuppliedbyUCSC	i_ORegAnno_bin	i_UniProt_alt_uniprot_accessions	i_annotation_transcript	i_build	i_ccds_id	i_dbNSFP_1000Gp1_AC	i_dbNSFP_1000Gp1_AF	i_dbNSFP_1000Gp1_AFR_AC	i_dbNSFP_1000Gp1_AFR_AF	i_dbNSFP_1000Gp1_AMR_AC	i_dbNSFP_1000Gp1_AMR_AF	i_dbNSFP_1000Gp1_ASN_AC	i_dbNSFP_1000Gp1_ASN_AF	i_dbNSFP_1000Gp1_EUR_AC	i_dbNSFP_1000Gp1_EUR_AF	i_dbNSFP_Ancestral_allele	i_dbNSFP_CADD_phred	i_dbNSFP_CADD_raw	i_dbNSFP_CADD_raw_rankscore	i_dbNSFP_ESP6500_AA_AF	i_dbNSFP_ESP6500_EA_AF	i_dbNSFP_Ensembl_geneid	i_dbNSFP_Ensembl_transcriptid	i_dbNSFP_FATHMM_pred	i_dbNSFP_FATHMM_rankscore	i_dbNSFP_FATHMM_score	i_dbNSFP_GERP_NR	i_dbNSFP_GERP_RS	i_dbNSFP_GERP_RS_rankscore	i_dbNSFP_Interpro_domain	i_dbNSFP_LRT_Omega	i_dbNSFP_LRT_converted_rankscore	i_dbNSFP_LRT_pred	i_dbNSFP_LRT_score	i_dbNSFP_LR_pred	i_dbNSFP_LR_rankscore	i_dbNSFP_LR_score	i_dbNSFP_MutationAssessor_pred	i_dbNSFP_MutationAssessor_rankscore	i_dbNSFP_MutationAssessor_score	i_dbNSFP_MutationTaster_converted_rankscore	i_dbNSFP_MutationTaster_pred	i_dbNSFP_MutationTaster_score	i_dbNSFP_Polyphen2_HDIV_pred	i_dbNSFP_Polyphen2_HDIV_rankscore	i_dbNSFP_Polyphen2_HDIV_score	i_dbNSFP_Polyphen2_HVAR_pred	i_dbNSFP_Polyphen2_HVAR_rankscore	i_dbNSFP_Polyphen2_HVAR_score	i_dbNSFP_RadialSVM_pred	i_dbNSFP_RadialSVM_rankscore	i_dbNSFP_RadialSVM_score	i_dbNSFP_Reliability_index	i_dbNSFP_SIFT_converted_rankscore	i_dbNSFP_SIFT_pred	i_dbNSFP_SIFT_score	i_dbNSFP_SLR_test_statistic	i_dbNSFP_SiPhy_29way_logOdds	i_dbNSFP_SiPhy_29way_logOdds_rankscore	i_dbNSFP_SiPhy_29way_pi	i_dbNSFP_UniSNP_ids	i_dbNSFP_Uniprot_aapos	i_dbNSFP_Uniprot_acc	i_dbNSFP_Uniprot_id	i_dbNSFP_aaalt	i_dbNSFP_aapos	i_dbNSFP_aapos_FATHMM	i_dbNSFP_aapos_SIFT	i_dbNSFP_aaref	i_dbNSFP_cds_strand	i_dbNSFP_codonpos	i_dbNSFP_folddegenerate	i_dbNSFP_genename	i_dbNSFP_hg18_pos1coor	i_dbNSFP_phastCons100way_vertebrate	i_dbNSFP_phastCons100way_vertebrate_rankscore	i_dbNSFP_phastCons46way_placental	i_dbNSFP_phastCons46way_placental_rankscore	i_dbNSFP_phastCons46way_primate	i_dbNSFP_phastCons46way_primate_rankscore	i_dbNSFP_phyloP100way_vertebrate	i_dbNSFP_phyloP100way_vertebrate_rankscore	i_dbNSFP_phyloP46way_placental	i_dbNSFP_phyloP46way_placental_rankscore	i_dbNSFP_phyloP46way_primate	i_dbNSFP_phyloP46way_primate_rankscore	i_dbNSFP_refcodon	i_gencode_transcript_name	i_gencode_transcript_status	i_gencode_transcript_tags	i_gencode_transcript_type	i_gene_id	i_gene_type	i_havana_transcript	i_init_t_lod	i_judgement	i_secondary_variant_classification	i_strand	i_t_lod_fstar	i_tumor_f	t_alt_count	t_ref_count	validation_alt_allele	validation_method	validation_status	validation_tumor_sample	validation_judgement_rna	validation_power_rna	validation_tumor_alt_count_rna	validation_tumor_ref_count_rna	validation_normal_alt_count_rna	validation_normal_ref_count_rna	discovery_tumor_alt_count_rna	discovery_tumor_ref_count_rna	discovery_normal_alt_count_rna	discovery_normal_ref_count_rna	min_val_count_rna	validation_judgement_targeted	validation_power_targeted	validation_tumor_alt_count_targeted	validation_tumor_ref_count_targeted	validation_normal_alt_count_targeted	validation_normal_ref_count_targeted	discovery_tumor_alt_count_targeted	discovery_tumor_ref_count_targeted	discovery_normal_alt_count_targeted	discovery_normal_ref_count_targeted	min_val_count_targeted	validation_status_consensus
GJB3	2707	broad.mit.edu	37	1	35250842	35250842	+	Missense_Mutation	SNP	G	G	A			GBM-TCGA-02-0055-Tumor-SM-1QUD8	GBM-TCGA-02-0055-Normal-SM-1QUDW	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-02-0055-Tumor-SM-1QUD8	GBM-TCGA-02-0055-Normal-SM-1QUDW	g.chr1:35250842G>A	ENST00000373366.2	+	2	1094	c.479G>A	c.(478-480)cGc>cAc	p.R160H	GJB3_ENST00000373362.3_Missense_Mutation_p.R160H|RP1-34M23.5_ENST00000542839.1_RNA	NM_024009.2	NP_076872.1	O75712	CXB3_HUMAN	gap junction protein, beta 3, 31kDa	160		NA		NA	cell communication	connexon complex|integral to membrane	gap junction channel activity	p.R160H(1)		central_nervous_system(1)|endometrium(2)|haematopoietic_and_lymphoid_tissue(1)|kidney(2)|large_intestine(4)|lung(2)|prostate(3)	15		Myeloproliferative disorder(586;0.0255)|all_neural(195;0.234)				AATATGCCGCGCCTGGTGCAG	0.552	NA	NA					NA				NA	NA	g	1	5e-04	NA	0.0028	2184	NA	0.9999	,	,	NA	3e-04	NA	NA	NA	5e-04	0.9049	EXOME	NA	NA	4e-04	SNP								NA		NA		1	Substitution - Missense(1)	endometrium(1)					NA		HIS/ARG,HIS/ARG	2,4404	2.1+/-5.4	0,2,2201	152	162	159	NA	479,479	5.1	1	1		159	4,8596	4.3+/-15.6	0,4,4296	yes	missense,missense	GJB3	NM_001005752.1,NM_024009.2	29,29	0,6,6497	AA,AG,GG	NA	0.0465,0.0454,0.0461	possibly-damaging,possibly-damaging	160/271,160/271	35250842	6,13000	2203	4300	6503	SO:0001583	missense			ENSG00000188910	HGNC:4285	NM_024009	Approved	uc001bxy.3	NA	B2R790|Q2TAZ8	ENST00000373366.2	37	CCDS384.1	1	4.578754578754579E-4	0	0.0	1	0.0027624309392265192	0	0.0	0	0.0	g	10.40	1.340688	0.24339	4.54E-4	4.65E-4	ENSG00000188910	ENST00000373366;ENST00000373362;ENST00000543647	D;D	0.95656	-3.77;-3.77	5.07	5.07	0.68467	Gap junction protein, cysteine-rich domain (1);	0.109633	0.64402	N	0.000017	D	0.92176	0.7519	M	0.61703	1.905	0.47476	D	0.999435	P	0.38300	0.626	B	0.23574	0.047	D	0.91616	0.5307	10	0.36615	T	0.2	.	13.7745	0.63046	0.0:0.154:0.846:0.0	.	160	O75712	CXB3_HUMAN	H	160;160;144	ENSP00000362464:R160H;ENSP00000362460:R160H	ENSP00000362460:R160H	R	+	2	0	GJB3	35023429	1.000000	0.71417	0.997000	0.53966	0.019000	0.09904	7.821000	0.86641	2.368000	0.80403	0.556000	0.70494	CGC	GJB3-002	KNOWN	alternative_5_UTR|basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000011559.1	152.121817	KEEP		+	155.664236	0.345238	58	110	---	---	---	---	1	0.813301	3	5	0	160	64	123	0	160	2	0	0	0	0	0	0	64	123	0	160	2	TP
COL11A1	1301	broad.mit.edu	37	1	103453212	103453212	+	Missense_Mutation	SNP	G	G	A			GBM-TCGA-02-0055-Tumor-SM-1QUD8	GBM-TCGA-02-0055-Normal-SM-1QUDW	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-02-0055-Tumor-SM-1QUD8	GBM-TCGA-02-0055-Normal-SM-1QUDW	g.chr1:103453212G>A	ENST00000358392.2	-	30	2832	c.2515C>T	c.(2515-2517)Cct>Tct	p.P839S	COL11A1_ENST00000353414.4_Missense_Mutation_p.P788S|COL11A1_ENST00000512756.1_Missense_Mutation_p.P711S|COL11A1_ENST00000370096.3_Missense_Mutation_p.P827S	NM_080629.2	NP_542196.2	P12107	COBA1_HUMAN	collagen, type XI, alpha 1	827	Triple-helical region.	NA		NA	collagen fibril organization|detection of mechanical stimulus involved in sensory perception of sound|visual perception	collagen type XI	extracellular matrix binding|extracellular matrix structural constituent|protein binding, bridging	p.P839S(1)		NS(3)|biliary_tract(1)|breast(5)|central_nervous_system(2)|cervix(1)|endometrium(17)|kidney(8)|large_intestine(28)|lung(157)|ovary(6)|pancreas(2)|prostate(6)|skin(9)|stomach(1)|upper_aerodigestive_tract(11)|urinary_tract(1)	258		all_epithelial(167;2.52e-07)|all_lung(203;3.11e-05)|Lung NSC(277;6.61e-05)|Breast(1374;0.181)		Lung(183;0.186)|all cancers(265;0.242)|Epithelial(280;0.248)		TGACCTGAAGGACCTGGGTCT	0.453	NA	NA					NA				NA	NA		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA		NA		1	Substitution - Missense(1)	central_nervous_system(1)					NA						88	84	85	NA		NA	NA	1		NA											NA				103453212		2203	4300	6503	SO:0001583	missense			ENSG00000060718	HGNC:2186	NM_080630	Approved	uc001dul.3	NA	B1ASK7|D3DT73|Q14034|Q9UIT4|Q9UIT5|Q9UIT6	ENST00000358392.2	37		.	.	.	.	.	.	.	.	.	.	G	15.09	2.729540	0.48833	.	.	ENSG00000060718	ENST00000370096;ENST00000358392;ENST00000353414;ENST00000512756	D;D;D;D	0.97665	-4.48;-4.48;-4.48;-4.48	4.39	3.39	0.38822	.	0.214637	0.39985	N	0.001203	D	0.95815	0.8638	M	0.61703	1.905	0.51482	D	0.999925	P;B;B;B	0.37636	0.603;0.03;0.03;0.018	P;B;B;B	0.46320	0.512;0.034;0.034;0.015	D	0.96186	0.9134	10	0.56958	D	0.05	.	13.4102	0.60938	0.0:0.2364:0.7636:0.0	.	711;788;839;827	E9PCU0;P12107-3;P12107-2;P12107	.;.;.;COBA1_HUMAN	S	827;839;788;711	ENSP00000359114:P827S;ENSP00000351163:P839S;ENSP00000302551:P788S;ENSP00000426533:P711S	ENSP00000302551:P788S	P	-	1	0	COL11A1	103225800	1.000000	0.71417	1.000000	0.80357	0.459000	0.32528	3.588000	0.53964	2.417000	0.82017	0.460000	0.39030	CCT	COL11A1-202	KNOWN	basic	protein_coding	NA	protein_coding		174.326655	KEEP		-	174.853848	0.432836	58	76	---	---	---	---	1	1	49	54	0	169	64	87	0	169	2	0	0	0	0	0	0	64	87	0	169	2	TP
PPIG	9360	broad.mit.edu	37	2	170494029	170494029	+	Missense_Mutation	SNP	G	G	C			GBM-TCGA-02-0055-Tumor-SM-1QUD8	GBM-TCGA-02-0055-Normal-SM-1QUDW	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-02-0055-Tumor-SM-1QUD8	GBM-TCGA-02-0055-Normal-SM-1QUDW	g.chr2:170494029G>C	ENST00000260970.3	+	14	2481	c.2261G>C	c.(2260-2262)gGa>gCa	p.G754A	PPIG_ENST00000448752.2_Missense_Mutation_p.G754A|PPIG_ENST00000409714.3_Missense_Mutation_p.G739A	NM_004792.2	NP_004783.2	Q13427	PPIG_HUMAN	peptidylprolyl isomerase G (cyclophilin G)	754		NA		NA	protein folding|RNA splicing	nuclear matrix|nuclear speck	cyclosporin A binding|peptidyl-prolyl cis-trans isomerase activity			NS(2)|breast(2)|central_nervous_system(2)|cervix(1)|endometrium(4)|kidney(2)|large_intestine(8)|liver(1)|lung(17)|ovary(2)|stomach(1)|urinary_tract(1)	43					L-Proline(DB00172)	GACAAAAGCGGATGAGTGAGT	0.313	NA	NA					NA				NA	NA		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA		NA		0							NA						31	34	33	NA		NA	NA	2		NA											NA				170494029		2003	3786	5789	SO:0001583	missense			ENSG00000138398	HGNC:14650		Approved	uc002uez.3	NA	D3DPC5|D3DPC6|O00706|Q53R40|Q53SN4|Q96DG9	ENST00000260970.3	37	CCDS2235.1	.	.	.	.	.	.	.	.	.	.	G	15.43	2.832089	0.50845	.	.	ENSG00000138398	ENST00000260970;ENST00000409714;ENST00000448752	T;T;T	0.21191	2.04;2.02;2.04	6.08	6.08	0.98989	.	0.000000	0.56097	D	0.000024	T	0.34658	0.0905	N	0.19112	0.55	0.37876	D	0.930219	D;D;D	0.76494	0.999;0.999;0.999	D;D;D	0.81914	0.995;0.995;0.995	T	0.22103	-1.0226	10	0.87932	D	0	.	18.8526	0.92238	0.0:0.0:1.0:0.0	.	739;739;754	E9PG73;Q2NKQ6;Q13427	.;.;PPIG_HUMAN	A	754;739;754	ENSP00000260970:G754A;ENSP00000386245:G739A;ENSP00000407083:G754A	ENSP00000260970:G754A	G	+	2	0	PPIG	170202275	1.000000	0.71417	1.000000	0.80357	0.740000	0.42216	4.712000	0.61888	2.894000	0.99253	0.591000	0.81541	GGA	PPIG-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000255264.2	29.65084	KEEP		+	37.681768	0.162162	12	62	---	---	---	---	1	0.9999891	34	89	0	115	13	67	0	115	2	0	0	0	0	0	0	13	67	0	115	2	TP
COL6A3	1293	broad.mit.edu	37	2	238275663	238275663	+	Missense_Mutation	SNP	G	G	A			GBM-TCGA-02-0055-Tumor-SM-1QUD8	GBM-TCGA-02-0055-Normal-SM-1QUDW	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-02-0055-Tumor-SM-1QUD8	GBM-TCGA-02-0055-Normal-SM-1QUDW	g.chr2:238275663G>A	ENST00000295550.4	-	11	5619	c.5167C>T	c.(5167-5169)Ctt>Ttt	p.L1723F	COL6A3_ENST00000472056.1_Missense_Mutation_p.L1116F|COL6A3_ENST00000409809.1_Missense_Mutation_p.L1517F|COL6A3_ENST00000347401.3_Missense_Mutation_p.L1522F|COL6A3_ENST00000346358.4_Missense_Mutation_p.L1523F|COL6A3_ENST00000353578.4_Missense_Mutation_p.L1517F	NM_004369.3	NP_004360.2	P12111	CO6A3_HUMAN	collagen, type VI, alpha 3	1723	Nonhelical region.|VWFA 9.	NA		NA	axon guidance|cell adhesion|muscle organ development	collagen type VI|extracellular space	serine-type endopeptidase inhibitor activity	p.L1723I(1)		breast(6)|central_nervous_system(7)|cervix(3)|endometrium(7)|haematopoietic_and_lymphoid_tissue(2)|kidney(13)|large_intestine(64)|lung(62)|ovary(14)|pancreas(2)|prostate(11)|skin(14)|stomach(2)|upper_aerodigestive_tract(6)|urinary_tract(4)	217		Breast(86;0.000301)|Renal(207;0.000966)|all_hematologic(139;0.067)|Ovarian(221;0.0694)|all_lung(227;0.0943)|Melanoma(123;0.203)		Epithelial(121;1.23e-21)|OV - Ovarian serous cystadenocarcinoma(60;1.34e-10)|Kidney(56;5.71e-09)|KIRC - Kidney renal clear cell carcinoma(57;1.51e-07)|BRCA - Breast invasive adenocarcinoma(100;0.00025)|Lung(119;0.0142)|LUSC - Lung squamous cell carcinoma(224;0.034)		AGGTGCTCAAGGCCCACCTTA	0.547	NA	NA					NA				NA	NA		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA		NA		1	Substitution - Missense(1)	lung(1)					NA						88	74	79	NA		NA	NA	2		NA											NA				238275663		2203	4300	6503	SO:0001583	missense			ENSG00000163359	HGNC:2213	NM_004369	Approved	uc002vwl.2	NA	Q16501|Q53QF4|Q53QF6	ENST00000295550.4	37	CCDS33412.1	.	.	.	.	.	.	.	.	.	.	G	9.170	1.020955	0.19433	.	.	ENSG00000163359	ENST00000295550;ENST00000347401;ENST00000353578;ENST00000472056;ENST00000409809;ENST00000346358	D;D;D;D;D;D	0.88046	-2.33;-2.33;-2.33;-2.33;-2.33;-2.33	5.56	-11.1	0.00147	von Willebrand factor, type A (3);	0.384550	0.21216	N	0.078240	D	0.91405	0.7288	M	0.79926	2.475	0.23082	N	0.998324	D;D;P	0.71674	0.998;0.991;0.782	D;P;B	0.70935	0.971;0.908;0.42	D	0.90520	0.4488	10	0.72032	D	0.01	.	21.1142	0.99946	0.0:0.0614:0.0909:0.8477	.	1116;1517;1723	E9PFQ6;P12111-2;P12111	.;.;CO6A3_HUMAN	F	1723;1522;1517;1116;1517;1523	ENSP00000295550:L1723F;ENSP00000315609:L1522F;ENSP00000315873:L1517F;ENSP00000418285:L1116F;ENSP00000386844:L1517F;ENSP00000295546:L1523F	ENSP00000295550:L1723F	L	-	1	0	COL6A3	237940402	0.369000	0.25039	0.005000	0.12908	0.088000	0.18126	-0.424000	0.07025	-2.547000	0.00482	-1.036000	0.02392	CTT	COL6A3-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000315790.2	76.85306	KEEP		-	78.573605	0.337838	25	49	---	---	---	---	1	1	136	230	0	56	28	62	0	56	2	0	0	0	0	0	0	28	62	0	56	2	TP
CTBP1	1487	broad.mit.edu	37	4	1209830	1209830	+	Silent	SNP	G	G	A			GBM-TCGA-02-0055-Tumor-SM-1QUD8	GBM-TCGA-02-0055-Normal-SM-1QUDW	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-02-0055-Tumor-SM-1QUD8	GBM-TCGA-02-0055-Normal-SM-1QUDW	g.chr4:1209830G>A	ENST00000382952.3	-	6	1062	c.678C>T	c.(676-678)tgC>tgT	p.C226C	CTBP1_ENST00000290921.6_Silent_p.C237C	NM_001012614.1	NP_001012632.1	Q13363	CTBP1_HUMAN	C-terminal binding protein 1	237		NA		NA	interspecies interaction between organisms|negative regulation of cell proliferation|negative regulation of histone H4 acetylation|negative regulation of transcription from RNA polymerase II promoter|positive regulation of histone deacetylation|protein phosphorylation|regulation of cell cycle|regulation of transcription by chromatin organization|regulation of transcription from RNA polymerase II promoter by nuclear hormone receptor|viral genome replication|white fat cell differentiation	cytoplasm|transcriptional repressor complex	NAD binding|oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor|protein C-terminus binding|protein domain specific binding|transcription factor binding			endometrium(1)|kidney(1)|large_intestine(1)|lung(2)|ovary(1)|skin(1)|urinary_tract(1)	8			OV - Ovarian serous cystadenocarcinoma(23;0.00818)	Colorectal(103;0.2)		CGTTGAGGCCGCAGTGCAGGG	0.637	NA	NA					NA				NA	NA		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA		NA		0							NA	G	,	1,4401	2.1+/-5.4	0,1,2200	115	94	101	NA	678,711	3.8	1	4		101	0,8598		0,0,4299	no	coding-synonymous,coding-synonymous	CTBP1	NM_001012614.1,NM_001328.2	,	0,1,6499	AA,AG,GG	NA	0.0,0.0227,0.0077	,	226/430,237/441	1209830	1,12999	2201	4299	6500	SO:0001819	synonymous_variant			ENSG00000159692	HGNC:2494	NM_001328	Approved	uc003gcv.1	NA	Q4W5N3	ENST00000382952.3	37	CCDS43203.1	.	.	.	.	.	.	.	.	.	.	G	4.680	0.126494	0.08931	2.27E-4	0.0	ENSG00000159692	ENST00000504092	.	.	.	4.62	3.76	0.43208	.	.	.	.	.	T	0.69269	0.3092	.	.	.	0.80722	D	1	.	.	.	.	.	.	T	0.67772	-0.5584	4	.	.	.	-20.8454	13.929	0.63981	0.0:0.0:0.8466:0.1534	.	.	.	.	W	84	.	.	R	-	1	2	CTBP1	1199830	1.000000	0.71417	1.000000	0.80357	0.178000	0.23041	3.001000	0.49488	0.901000	0.36495	0.561000	0.74099	CGG	CTBP1-003	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000359459.1	-2.007279	KEEP		-	6.478085	0.068182	3	41	---	---	---	---	1	0.9995438	2	470	0	35	3	50	0	35	2	0	0	0	0	0	0	3	50	0	35	2	TP
AFM	173	broad.mit.edu	37	4	74354406	74354406	+	Missense_Mutation	SNP	T	T	C	rs139224995	byFrequency	GBM-TCGA-02-0055-Tumor-SM-1QUD8	GBM-TCGA-02-0055-Normal-SM-1QUDW	NA	NA	NA	NA	NA	NA	NA	Untested,Invalid,Invalid,Valid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-02-0055-Tumor-SM-1QUD8	GBM-TCGA-02-0055-Normal-SM-1QUDW	g.chr4:74354406T>C	ENST00000226355.3	+	7	866	c.773T>C	c.(772-774)cTt>cCt	p.L258P		NM_001133.2	NP_001124.1	P43652	AFAM_HUMAN	afamin	258	Albumin 2.	NA		NA	vitamin transport		vitamin E binding			breast(2)|central_nervous_system(2)|endometrium(2)|kidney(1)|large_intestine(8)|lung(9)|ovary(2)|skin(2)|upper_aerodigestive_tract(2)|urinary_tract(2)	32	Breast(15;0.00102)		Epithelial(6;5.69e-05)|OV - Ovarian serous cystadenocarcinoma(6;0.000324)|all cancers(17;0.000555)|Lung(101;0.103)|LUSC - Lung squamous cell carcinoma(112;0.154)			CTTATTTCTCTTGTAGAAGAT	0.353	NA	NA					NA				NA	NA		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA		NA		0							NA	T	PRO/LEU	1,4405	2.1+/-5.4	0,1,2202	116	118	118	NA	773	5.4	0	4	dbSNP_134	118	2,8598	2.2+/-6.3	0,2,4298	yes	missense	AFM	NM_001133.2	98	0,3,6500	CC,CT,TT	NA	0.0233,0.0227,0.0231	probably-damaging	258/600	74354406	3,13003	2203	4300	6503	SO:0001583	missense			ENSG00000079557	HGNC:316		Approved	uc003hhb.3	NA	A8K3E1|Q32MR3|Q4W5C5	ENST00000226355.3	37	CCDS3557.1	.	.	.	.	.	.	.	.	.	.	T	11.59	1.684041	0.29872	2.27E-4	2.33E-4	ENSG00000079557	ENST00000226355	D	0.83755	-1.76	5.36	5.36	0.76844	Serum albumin-like (1);Serum albumin, N-terminal (3);	0.420015	0.23859	N	0.043872	D	0.91250	0.7242	M	0.86740	2.835	0.26330	N	0.977538	D	0.76494	0.999	D	0.72338	0.977	D	0.85776	0.1358	10	0.87932	D	0	.	11.7832	0.52026	0.0:0.0:0.0:1.0	.	258	P43652	AFAM_HUMAN	P	258	ENSP00000226355:L258P	ENSP00000226355:L258P	L	+	2	0	AFM	74573270	0.027000	0.19231	0.036000	0.18154	0.005000	0.04900	2.447000	0.44917	2.042000	0.60477	0.533000	0.62120	CTT	AFM-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000252275.2	213.405968	KEEP		+	216.460003	0.358382	62	111	---	---	---	---	0	0	0	0	0	210	66	117	0	210	2	1	1	64	91	0	157	66	117	0	210	2	TP
FAT4	79633	broad.mit.edu	37	4	126373451	126373451	+	Silent	SNP	G	G	A			GBM-TCGA-02-0055-Tumor-SM-1QUD8	GBM-TCGA-02-0055-Normal-SM-1QUDW	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-02-0055-Tumor-SM-1QUD8	GBM-TCGA-02-0055-Normal-SM-1QUDW	g.chr4:126373451G>A	ENST00000394329.3	+	9	11293	c.11280G>A	c.(11278-11280)acG>acA	p.T3760T	FAT4_ENST00000335110.5_Silent_p.T2058T	NM_024582.4	NP_078858.4	Q6V0I7	FAT4_HUMAN	FAT atypical cadherin 4	3760		NA		NA	homophilic cell adhesion	integral to membrane|plasma membrane	calcium ion binding			NS(6)|autonomic_ganglia(1)|breast(4)|central_nervous_system(3)|cervix(3)|endometrium(27)|haematopoietic_and_lymphoid_tissue(3)|kidney(10)|large_intestine(93)|liver(3)|lung(120)|ovary(9)|pancreas(2)|prostate(21)|skin(31)|stomach(1)|upper_aerodigestive_tract(12)|urinary_tract(6)	355						ACAATAGAACGTTTCTTTTGG	0.453	NA	NA					NA				NA	NA		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA		NA		0							NA						106	102	104	NA		NA	NA	4		NA											NA				126373451		2203	4300	6503	SO:0001819	synonymous_variant			ENSG00000196159	HGNC:23109	NM_024582	Approved	uc003ifj.4	NA	A8K5Z6|B5MDG4|Q3LIA6|Q8TCK7|Q9H5T6	ENST00000394329.3	37	CCDS3732.3																																																																																			FAT4-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000256765.2	-15.84427	KEEP		+	30.11002	0.064378	15	218	---	---	---	---	1	0.0789746	2	5	0	210	16	233	0	210	2	0	0	0	0	0	0	16	233	0	210	2	TP
CYCS	0	broad.mit.edu	37	7	25163649	25163649	+	Silent	SNP	C	C	T			GBM-TCGA-02-0055-Tumor-SM-1QUD8	GBM-TCGA-02-0055-Normal-SM-1QUDW	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-02-0055-Tumor-SM-1QUD8	GBM-TCGA-02-0055-Normal-SM-1QUDW	g.chr7:25163649C>T	ENST00000305786.2	-	2	259	c.90G>A	c.(88-90)ggG>ggA	p.G30G	CYCS_ENST00000409764.1_Silent_p.G30G|CYCS_ENST00000409409.1_Silent_p.G30G	NM_018947.5	NP_061820.1	P99999	CYC_HUMAN	cytochrome c, somatic	30		NA		NA	activation of caspase activity by cytochrome c|DNA fragmentation involved in apoptotic nuclear change|induction of apoptosis by intracellular signals|respiratory electron transport chain|transport	cytosol|mitochondrial inner membrane|mitochondrial intermembrane space|mitochondrial matrix|nucleus|protein phosphatase type 2A complex|respiratory chain	electron transporter, transferring electrons from CoQH2-cytochrome c reductase complex and cytochrome c oxidase complex activity|heme binding|protein binding			endometrium(1)|lung(1)|ovary(1)|upper_aerodigestive_tract(1)	4					Melatonin(DB01065)|Minocycline(DB01017)	GGAGATTTGGCCCAGTCTTGT	0.443	NA	NA					NA				NA	NA		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA		NA		0							NA						54	56	56	NA		NA	NA	7		NA											NA				25163649		2203	4300	6503	SO:0001819	synonymous_variant			ENSG00000172115	HGNC:19986		Approved	uc003sxl.3	NA	A4D166|B2R4I1|P00001|Q6NUR2|Q6NX69|Q96BV4	ENST00000305786.2	37	CCDS5393.1																																																																																			CYCS-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000250299.2	-30.976221	KEEP		-	6.880306	0.026144	4	149	---	---	---	---	1	0.9999635	7	1527	0	100	4	153	0	100	2	0	0	0	0	0	0	4	153	0	100	2	TP
JHDM1D	0	broad.mit.edu	37	7	139824534	139824534	+	Missense_Mutation	SNP	C	C	T			GBM-TCGA-02-0055-Tumor-SM-1QUD8	GBM-TCGA-02-0055-Normal-SM-1QUDW	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-02-0055-Tumor-SM-1QUD8	GBM-TCGA-02-0055-Normal-SM-1QUDW	g.chr7:139824534C>T	ENST00000397560.2	-	7	1035	c.938G>A	c.(937-939)cGt>cAt	p.R313H	JHDM1D_ENST00000006967.5_Missense_Mutation_p.R313H	NM_030647.1	NP_085150.1	Q6ZMT4	KDM7_HUMAN		313	JmjC.	NA		NA	midbrain development|transcription, DNA-dependent	nucleolus	histone demethylase activity (H3-K27 specific)|histone demethylase activity (H3-K36 specific)|histone demethylase activity (H3-K9 specific)|histone demethylase activity (H4-K20 specific)|iron ion binding|methylated histone residue binding|oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen|zinc ion binding			central_nervous_system(2)|endometrium(4)|kidney(1)|large_intestine(1)|lung(10)|ovary(1)|prostate(1)|skin(1)|stomach(1)	22	Melanoma(164;0.0142)					AGATTCATAACGTGCCAAATT	0.358	NA	NA					NA				NA	NA		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA		NA		0							NA	C	HIS/ARG	0,3682		0,0,1841	95	86	89	NA	938	4.3	1	7		89	3,8177		0,3,4087	no	missense	JHDM1D	NM_030647.1	29	0,3,5928	TT,TC,CC	NA	0.0367,0.0,0.0253	benign	313/942	139824534	3,11859	1841	4090	5931	SO:0001583	missense								NA	A4D1S9|C9JJH9|C9JQU2|Q6MZL8|Q9C0E5	ENST00000397560.2	37	CCDS43658.1	.	.	.	.	.	.	.	.	.	.	C	18.23	3.577367	0.65878	0.0	3.67E-4	ENSG00000006459	ENST00000397560;ENST00000006967	T;T	0.71817	-0.6;-0.6	5.49	4.34	0.51931	Transcription factor jumonji/aspartyl beta-hydroxylase (2);Transcription factor jumonji (1);	0.060735	0.64402	D	0.000002	T	0.52435	0.1734	N	0.16656	0.425	0.35337	D	0.786138	B	0.30686	0.29	B	0.13407	0.009	T	0.62296	-0.6884	10	0.87932	D	0	-3.5299	12.7856	0.57502	0.8568:0.1432:0.0:0.0	.	313	Q6ZMT4	KDM7_HUMAN	H	313	ENSP00000380692:R313H;ENSP00000006967:R313H	ENSP00000006967:R313H	R	-	2	0	JHDM1D	139471003	1.000000	0.71417	1.000000	0.80357	0.987000	0.75469	5.085000	0.64468	1.021000	0.39600	-0.262000	0.10625	CGT	JHDM1D-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000348460.1	62.332368	KEEP		-	66.494696	0.274725	25	66	---	---	---	---	1	0.8731916	3	9	0	87	26	69	0	87	2	0	0	0	0	0	0	26	69	0	87	2	TP
PLAG1	5324	broad.mit.edu	37	8	57079222	57079222	+	Missense_Mutation	SNP	C	C	T			GBM-TCGA-02-0055-Tumor-SM-1QUD8	GBM-TCGA-02-0055-Normal-SM-1QUDW	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-02-0055-Tumor-SM-1QUD8	GBM-TCGA-02-0055-Normal-SM-1QUDW	g.chr8:57079222C>T	ENST00000316981.3	-	5	1562	c.1083G>A	c.(1081-1083)atG>atA	p.M361I	PLAG1_ENST00000423799.2_Missense_Mutation_p.M279I|PLAG1_ENST00000429357.2_Missense_Mutation_p.M361I	NM_001114634.1|NM_002655.2	NP_001108106.1|NP_002646.2	Q6DJT9	PLAG1_HUMAN	pleiomorphic adenoma gene 1	361	Activates transcription; Inhibition of nuclear import due to lack of NLS and KPNA2 interaction.|Repression domain; contains 3 sumoylation motifs and massively decrease transcription activity.	NA		NA		nucleus	DNA binding|sequence-specific DNA binding transcription factor activity|zinc ion binding	p.M361I(1)	CTNNB1/PLAG1(60)|LIFR_ENST00000263409/PLAG1(10)|HAS2/PLAG1(10)|FGFR1_ENST00000447712/PLAG1(28)|COL1A2/PLAG1(3)|CHCHD7/PLAG1(12)|TCEA1_ENST00000521604/PLAG1(3)	breast(3)|central_nervous_system(1)|cervix(1)|kidney(2)|large_intestine(7)|lung(11)|prostate(1)|skin(1)|upper_aerodigestive_tract(1)	28		all_lung(136;0.0548)|Lung NSC(129;0.0718)|all_epithelial(80;0.125)	Epithelial(17;0.00179)|all cancers(17;0.0125)			CTTGTAACTCCATCAGGTAAC	0.438	NA	NA	T	"""TCEA1, LIFR, CTNNB1, CHCHD7"""	salivary adenoma		NA				NA	NA		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA				Dom	yes		8	8q12	5324	pleiomorphic adenoma gene 1	NA	E	1	Substitution - Missense(1)	central_nervous_system(1)					NA						125	120	122	NA		NA	NA	8		NA											NA				57079222		2203	4300	6503	SO:0001583	missense				HGNC:9045	NM_002655	Approved	uc010lyi.3	NA	Q59GH8|Q9Y4L2	ENST00000316981.3	37	CCDS6165.1	.	.	.	.	.	.	.	.	.	.	C	6.133	0.392808	0.11638	.	.	ENSG00000181690	ENST00000316981;ENST00000423799;ENST00000429357	T;T;T	0.12147	2.71;3.41;2.71	5.78	5.78	0.91487	.	0.170124	0.64402	D	0.000005	T	0.13670	0.0331	L	0.43152	1.355	0.58432	D	0.999994	P	0.44090	0.826	B	0.37780	0.258	T	0.10706	-1.0618	10	0.12103	T	0.63	-19.758	20.0024	0.97423	0.0:1.0:0.0:0.0	.	361	Q6DJT9	PLAG1_HUMAN	I	361;279;361	ENSP00000325546:M361I;ENSP00000404067:M279I;ENSP00000416537:M361I	ENSP00000325546:M361I	M	-	3	0	PLAG1	57241776	1.000000	0.71417	1.000000	0.80357	0.951000	0.60555	4.630000	0.61297	2.722000	0.93159	0.467000	0.42956	ATG	PLAG1-003	KNOWN	alternative_5_UTR|basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000378212.1	237.961816	KEEP		-	245.93747	0.317164	85	183	---	---	---	---	1	0.8171583	3	6	0	231	100	224	0	231	2	0	0	0	0	0	0	100	224	0	231	2	TP
ZNF248	57209	broad.mit.edu	37	10	38126948	38126948	+	Missense_Mutation	SNP	A	A	G			GBM-TCGA-02-0055-Tumor-SM-1QUD8	GBM-TCGA-02-0055-Normal-SM-1QUDW	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-02-0055-Tumor-SM-1QUD8	GBM-TCGA-02-0055-Normal-SM-1QUDW	g.chr10:38126948A>G	ENST00000395867.3	-	4	657	c.107T>C	c.(106-108)gTg>gCg	p.V36A	ZNF248_ENST00000374648.3_Missense_Mutation_p.V36A|ZNF248_ENST00000357328.4_Missense_Mutation_p.V36A|ZNF248_ENST00000494133.1_5'UTR	NM_001267605.1|NM_001267606.1|NM_001267607.1|NM_021045.2	NP_001254534.1|NP_001254535.1|NP_001254536.1|NP_066383.1	Q8NDW4	ZN248_HUMAN	zinc finger protein 248	36	KRAB.	NA		NA	regulation of transcription, DNA-dependent|transcription, DNA-dependent	nucleus	DNA binding|zinc ion binding			NS(1)|endometrium(2)|large_intestine(5)|lung(9)|ovary(2)|urinary_tract(1)	20						TTCCAGGATCACATCTCTGTA	0.413	NA	NA					NA				NA	NA		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA		NA		0							NA						163	156	158	NA		NA	NA	10		NA											NA				38126948		2203	4300	6503	SO:0001583	missense			ENSG00000198105	HGNC:13041	NM_021045	Approved	uc010qeu.2	NA	Q9UMP3	ENST00000395867.3	37	CCDS7194.1	.	.	.	.	.	.	.	.	.	.	A	15.16	2.751437	0.49257	.	.	ENSG00000198105	ENST00000395867;ENST00000374648;ENST00000357328;ENST00000395873;ENST00000395874	T;T;T;T;T	0.03951	3.75;3.75;3.75;3.75;3.75	4.43	4.43	0.53597	Krueppel-associated box (4);	0.175886	0.27544	N	0.018900	T	0.32071	0.0817	H	0.97103	3.94	0.38525	D	0.948836	D;D	0.76494	0.999;0.992	D;P	0.85130	0.997;0.832	T	0.52548	-0.8561	10	0.87932	D	0	.	11.9297	0.52839	1.0:0.0:0.0:0.0	.	36;36	Q8NDW4;Q8NDV8	ZN248_HUMAN;.	A	36	ENSP00000379208:V36A;ENSP00000363778:V36A;ENSP00000349882:V36A;ENSP00000379214:V36A;ENSP00000379215:V36A	ENSP00000349882:V36A	V	-	2	0	ZNF248	38166954	1.000000	0.71417	1.000000	0.80357	0.218000	0.24690	4.328000	0.59253	1.976000	0.57569	0.460000	0.39030	GTG	ZNF248-004	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000047609.1	304.36504	KEEP		-	304.369952	0.495	99	101	---	---	---	---	1	0.974181	8	1	0	290	107	113	0	290	2	0	0	0	0	0	0	107	113	0	290	2	TP
PTEN	5728	broad.mit.edu	37	10	89692907	89692907	+	Missense_Mutation	SNP	A	A	G			GBM-TCGA-02-0055-Tumor-SM-1QUD8	GBM-TCGA-02-0055-Normal-SM-1QUDW	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Valid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-02-0055-Tumor-SM-1QUD8	GBM-TCGA-02-0055-Normal-SM-1QUDW	g.chr10:89692907A>G	ENST00000371953.3	+	5	1748	c.391A>G	c.(391-393)Act>Gct	p.T131A		NM_000314.4	NP_000305.3	P60484	PTEN_HUMAN	phosphatase and tensin homolog	131	Phosphatase tensin-type.	NA		NA	activation of mitotic anaphase-promoting complex activity|apoptosis|canonical Wnt receptor signaling pathway|cell proliferation|central nervous system development|induction of apoptosis|inositol phosphate dephosphorylation|negative regulation of cell migration|negative regulation of cyclin-dependent protein kinase activity involved in G1/S|negative regulation of focal adhesion assembly|negative regulation of G1/S transition of mitotic cell cycle|negative regulation of protein kinase B signaling cascade|negative regulation of protein phosphorylation|nerve growth factor receptor signaling pathway|phosphatidylinositol dephosphorylation|phosphatidylinositol-mediated signaling|positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process|positive regulation of sequence-specific DNA binding transcription factor activity|protein stabilization|regulation of neuron projection development|T cell receptor signaling pathway	cytosol|internal side of plasma membrane|PML body	anaphase-promoting complex binding|enzyme binding|inositol-1,3,4,5-tetrakisphosphate 3-phosphatase activity|lipid binding|magnesium ion binding|PDZ domain binding|phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity|phosphatidylinositol-3,4-bisphosphate 3-phosphatase activity|phosphatidylinositol-3-phosphatase activity|protein serine/threonine phosphatase activity|protein tyrosine phosphatase activity|protein tyrosine/serine/threonine phosphatase activity	p.0?(37)|p.?(5)|p.R55fs*1(5)|p.T131fs*3(3)|p.Y27fs*1(2)|p.K128_R130del(2)|p.T131A(1)|p.A121_F145del(1)|p.R130fs*2(1)|p.T131P(1)|p.F56fs*2(1)|p.K128fs*47(1)		NS(28)|autonomic_ganglia(2)|biliary_tract(6)|bone(5)|breast(92)|central_nervous_system(676)|cervix(26)|endometrium(1068)|eye(8)|haematopoietic_and_lymphoid_tissue(137)|kidney(24)|large_intestine(98)|liver(20)|lung(91)|meninges(2)|oesophagus(2)|ovary(82)|pancreas(6)|prostate(129)|salivary_gland(5)|skin(127)|soft_tissue(19)|stomach(30)|testis(1)|thyroid(29)|upper_aerodigestive_tract(29)|urinary_tract(12)|vulva(17)	2771		all_cancers(4;3.61e-31)|all_epithelial(4;3.96e-23)|Prostate(4;8.12e-23)|Breast(4;0.000111)|Melanoma(5;0.00146)|all_hematologic(4;0.00227)|Colorectal(252;0.00494)|all_neural(4;0.00513)|Acute lymphoblastic leukemia(4;0.0116)|Glioma(4;0.0274)|all_lung(38;0.132)	KIRC - Kidney renal clear cell carcinoma(1;0.214)	UCEC - Uterine corpus endometrioid carcinoma (6;0.000228)|all cancers(1;4.16e-84)|GBM - Glioblastoma multiforme(1;7.77e-49)|Epithelial(1;7.67e-41)|OV - Ovarian serous cystadenocarcinoma(1;6.22e-15)|BRCA - Breast invasive adenocarcinoma(1;1.1e-06)|Lung(2;3.18e-06)|Colorectal(12;4.88e-06)|LUSC - Lung squamous cell carcinoma(2;4.97e-06)|COAD - Colon adenocarcinoma(12;1.13e-05)|Kidney(1;0.000288)|KIRC - Kidney renal clear cell carcinoma(1;0.00037)|STAD - Stomach adenocarcinoma(243;0.218)		AAAGGGACGAACTGGTGTAAT	0.398	NA	31	"""D, Mis, N, F, S"""		"""glioma,  prostate, endometrial"""	"""harmartoma, glioma,  prostate, endometrial"""	NA		Proteus syndrome;Juvenile Polyposis;Hereditary Mixed Polyposis Syndrome type 1;Cowden syndrome;Bannayan-Riley-Ruvalcaba syndrome	HNSCC(9;0.0022)|TCGA GBM(2;<1E-08)|TSP Lung(26;0.18)	NA	NA		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA			yes	Rec	yes	"""Cowden Syndrome, Bannayan-Riley-Ruvalcaba syndrome"""	10	10q23.3	5728	phosphatase and tensin homolog gene	NA	"""L, E, M, O"""	60	Whole gene deletion(37)|Deletion - Frameshift(13)|Unknown(5)|Deletion - In frame(3)|Substitution - Missense(2)	prostate(16)|central_nervous_system(12)|endometrium(6)|skin(6)|ovary(6)|lung(5)|haematopoietic_and_lymphoid_tissue(4)|breast(3)|soft_tissue(1)|urinary_tract(1)					NA						139	129	132	NA		NA	NA	10		NA											NA				89692907		2203	4300	6503	SO:0001583	missense	Familial Cancer Database	Incl.: Encephalocraniocutaneous Lipomatosis, ECCL, Proteus-like s.;incl.: Juvenile Polyposis of the Stomach;HMPS1, Colorectal Adenoma Carcinoma syndrome, CRAC, CRAC1;CS, Cowden disease, Multiple Hamartoma Syndrome, incl.: Lhermitte-Duclos; part of PTEN hamartoma tumour syndrome (PHTS) / PTEN-MATCHS, Cowden-like syndrome;subset of PTEN-Hamartoma Tumor Syndrome; incl.: Ruvalcaba-Myhre-Smith s.	ENSG00000171862	HGNC:9588	NM_000314	Approved	uc001kfb.3	NA	B2R904|O00633|O02679|Q6ICT7	ENST00000371953.3	37	CCDS31238.1	.	.	.	.	.	.	.	.	.	.	A	26.5	4.743653	0.89663	.	.	ENSG00000171862	ENST00000371953	D	0.99369	-5.78	5.09	5.09	0.68999	Phosphatase tensin type (1);Dual specificity phosphatase, catalytic domain (1);	0.101247	0.64402	D	0.000003	D	0.99339	0.9768	M	0.81341	2.54	0.80722	D	1	D	0.76494	0.999	D	0.83275	0.996	D	0.99072	1.0834	9	.	.	.	-3.3726	14.8682	0.70434	1.0:0.0:0.0:0.0	.	131	P60484	PTEN_HUMAN	A	131	ENSP00000361021:T131A	.	T	+	1	0	PTEN	89682887	1.000000	0.71417	1.000000	0.80357	0.994000	0.84299	8.918000	0.92759	1.898000	0.54952	0.460000	0.39030	ACT	PTEN-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000049241.1	325.760728	KEEP		+	325.780696	0.511364	90	86	---	---	---	---	1	1	99	55	0	226	98	95	0	226	2	1	1	137	99	0	262	98	95	0	226	2	TP
PICALM	8301	broad.mit.edu	37	11	85733503	85733503	+	Missense_Mutation	SNP	A	A	T			GBM-TCGA-02-0055-Tumor-SM-1QUD8	GBM-TCGA-02-0055-Normal-SM-1QUDW	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-02-0055-Tumor-SM-1QUD8	GBM-TCGA-02-0055-Normal-SM-1QUDW	g.chr11:85733503A>T	ENST00000526033.1	-	4	675	c.359T>A	c.(358-360)aTg>aAg	p.M120K	PICALM_ENST00000393346.3_Missense_Mutation_p.M120K|PICALM_ENST00000356360.5_Missense_Mutation_p.M120K|PICALM_ENST00000528411.1_5'UTR|PICALM_ENST00000532317.1_Missense_Mutation_p.M120K|PICALM_ENST00000528398.1_Missense_Mutation_p.M69K	NM_001206946.1|NM_007166.3	NP_001193875.1|NP_009097.2	Q13492	PICAL_HUMAN	phosphatidylinositol binding clathrin assembly protein	120	ENTH.	NA		NA	clathrin coat assembly|endosome transport|negative regulation of receptor-mediated endocytosis|positive regulation of transcription, DNA-dependent|receptor internalization|regulation of protein localization	clathrin coat|clathrin-coated vesicle|coated pit|Golgi apparatus|nucleus|postsynaptic membrane|presynaptic membrane	1-phosphatidylinositol binding|clathrin heavy chain binding			endometrium(1)|kidney(2)|large_intestine(2)|liver(1)|lung(10)|ovary(1)|skin(1)|urinary_tract(1)	19		Acute lymphoblastic leukemia(157;7.42e-07)|all_hematologic(158;0.00092)				AAATGTAGACATGTCATATCC	0.303	NA	NA	T	"""MLLT10, MLL"""	"""TALL, AML, """		NA				NA	NA		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA				Dom	yes		11	11q14	8301	phosphatidylinositol binding clathrin assembly protein (CALM)	NA	L	0							NA						76	79	78	NA		NA	NA	11		NA											NA				85733503		2202	4294	6496	SO:0001583	missense			ENSG00000073921	HGNC:15514	NM_007166	Approved	uc001pbm.3	NA	O60700|Q6GMQ6|Q86XZ9	ENST00000526033.1	37	CCDS55784.1	.	.	.	.	.	.	.	.	.	.	A	21.1	4.095821	0.76870	.	.	ENSG00000073921	ENST00000532317;ENST00000526033;ENST00000447890;ENST00000393346;ENST00000528398;ENST00000356360;ENST00000531930;ENST00000525162;ENST00000528256	T;T;T;T;T;T;T;T	0.32753	1.44;1.44;1.44;1.44;1.44;1.44;1.44;1.44	5.34	5.34	0.76211	ENTH/VHS (2);ANTH (1);Epsin-like, N-terminal (2);	0.000000	0.85682	D	0.000000	T	0.54870	0.1885	M	0.71920	2.185	0.80722	D	1	D;D;D;D	0.89917	1.0;1.0;1.0;1.0	D;D;D;D	0.97110	0.999;1.0;0.997;1.0	T	0.55630	-0.8111	9	.	.	.	-17.7477	15.3632	0.74499	1.0:0.0:0.0:0.0	.	69;120;120;120	E9PN05;F8VPG7;Q13492;Q13492-3	.;.;PICAL_HUMAN;.	K	120;120;120;120;69;120;86;69;86	ENSP00000436958:M120K;ENSP00000433846:M120K;ENSP00000377015:M120K;ENSP00000434884:M69K;ENSP00000348718:M120K;ENSP00000433303:M86K;ENSP00000436508:M69K;ENSP00000431545:M86K	.	M	-	2	0	PICALM	85411151	1.000000	0.71417	1.000000	0.80357	0.969000	0.65631	9.252000	0.95491	2.026000	0.59711	0.378000	0.23410	ATG	PICALM-001	NOVEL	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000392221.1	108.864906	KEEP		-	112.034633	0.321429	36	76	---	---	---	---	1	1	53	136	0	174	37	77	0	174	2	0	0	0	0	0	0	37	77	0	174	2	TP
WIF1	11197	broad.mit.edu	37	12	65445111	65445111	+	3'UTR	SNP	C	C	T			GBM-TCGA-02-0055-Tumor-SM-1QUD8	GBM-TCGA-02-0055-Normal-SM-1QUDW	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-02-0055-Tumor-SM-1QUD8	GBM-TCGA-02-0055-Normal-SM-1QUDW	g.chr12:65445111C>T	ENST00000286574.4	-	0	1532					NM_007191.4	NP_009122.2	Q9Y5W5	WIF1_HUMAN	WNT inhibitory factor 1	NA		NA		NA	multicellular organismal development|Wnt receptor signaling pathway	extracellular region	protein tyrosine kinase activity			cervix(1)|large_intestine(4)|lung(10)|ovary(3)|skin(1)|stomach(1)|urinary_tract(1)	21			LUAD - Lung adenocarcinoma(6;0.0234)|LUSC - Lung squamous cell carcinoma(43;0.0975)	GBM - Glioblastoma multiforme(28;0.0231)		TAACTTAAAACGTTTCAGATG	0.428	NA	NA	T	HMGA2	pleomorphic salivary gland adenoma		NA				NA	NA		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA		Esophageal Squamous(148;1595 1816 48559 49439 49664)		Dom	yes		12	12q14.3	11197	WNT inhibitory factor 1	NA	E	0							NA						76	73	74	NA		NA	NA	12		NA											NA				65445111		2203	4300	6503	SO:0001624	3_prime_UTR_variant			ENSG00000156076	HGNC:18081		Approved	uc001ssk.3	NA	Q6UXI1|Q8WVG4	ENST00000286574.4	37	CCDS8971.1																																																																																			WIF1-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000401258.2	98.119161	KEEP		-	98.153057	0.52459	32	29	---	---	---	---	1	0.9998729	6	11	0	82	38	31	0	82	2	0	0	0	0	0	0	38	31	0	82	2	TP
UBC	7316	broad.mit.edu	37	12	125397201	125397201	+	Missense_Mutation	SNP	G	G	T			GBM-TCGA-02-0055-Tumor-SM-1QUD8	GBM-TCGA-02-0055-Normal-SM-1QUDW	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-02-0055-Tumor-SM-1QUD8	GBM-TCGA-02-0055-Normal-SM-1QUDW	g.chr12:125397201G>T	ENST00000536769.1	-	1	2693	c.1117C>A	c.(1117-1119)Ctg>Atg	p.L373M	MIR5188_ENST00000583467.1_RNA|UBC_ENST00000339647.5_Missense_Mutation_p.L373M|UBC_ENST00000538617.1_Intron|UBC_ENST00000546120.1_Missense_Mutation_p.L297M|UBC_ENST00000536661.1_5'Flank			P0CG48	UBC_HUMAN	ubiquitin C	373	Ubiquitin-like 5.	NA		NA	activation of MAPK activity|anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process|anti-apoptosis|apoptosis|cellular membrane organization|DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest|DNA repair|endosome transport|epidermal growth factor receptor signaling pathway|G1/S transition of mitotic cell cycle|I-kappaB kinase/NF-kappaB cascade|induction of apoptosis by extracellular signals|innate immune response|JNK cascade|M/G1 transition of mitotic cell cycle|mRNA metabolic process|MyD88-dependent toll-like receptor signaling pathway|MyD88-independent toll-like receptor signaling pathway|negative regulation of epidermal growth factor receptor signaling pathway|negative regulation of type I interferon production|negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle|nerve growth factor receptor signaling pathway|positive regulation of I-kappaB kinase/NF-kappaB cascade|positive regulation of NF-kappaB transcription factor activity|positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle|S phase of mitotic cell cycle|stress-activated MAPK cascade|T cell receptor signaling pathway|Toll signaling pathway|toll-like receptor 1 signaling pathway|toll-like receptor 2 signaling pathway|toll-like receptor 3 signaling pathway|toll-like receptor 4 signaling pathway|viral reproduction	cytosol|endocytic vesicle membrane|endosome membrane|nucleoplasm|plasma membrane	protein binding			breast(3)|endometrium(4)|kidney(4)|large_intestine(2)|lung(13)|ovary(3)|prostate(4)|skin(1)|upper_aerodigestive_tract(1)|urinary_tract(1)	36	all_neural(191;0.101)|Medulloblastoma(191;0.163)			OV - Ovarian serous cystadenocarcinoma(86;6.17e-05)|Epithelial(86;0.000207)|all cancers(50;0.00308)		CGGAGCACCAGGTGCAAGGTG	0.532	NA	NA					NA				NA	NA		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA		NA		0							NA						230	211	217	NA		NA	NA	12		NA											NA				125397201		2203	4300	6503	SO:0001583	missense			ENSG00000150991	HGNC:12468	NM_021009	Approved	uc001ugs.4	NA	P02248|P02249|P02250|P62988|Q29120|Q6LBL4|Q6LDU5|Q8WYN8|Q91887|Q91888|Q9BWD6|Q9BX98|Q9UEF2|Q9UEG1|Q9UEK8|Q9UPK7	ENST00000536769.1	37	CCDS9260.1	.	.	.	.	.	.	.	.	.	.	G	14.01	2.407639	0.42715	.	.	ENSG00000150991	ENST00000536769;ENST00000535460;ENST00000541046;ENST00000339647;ENST00000546120	T;T;T	0.47869	0.83;0.83;0.83	3.16	2.22	0.28083	Ubiquitin supergroup (1);Ubiquitin (2);	0.000000	0.36374	U	0.002623	T	0.61248	0.2332	M	0.67953	2.075	0.58432	D	0.999994	D;D;P	0.57571	0.98;0.975;0.943	D;D;D	0.76575	0.988;0.979;0.941	T	0.63686	-0.6581	10	0.87932	D	0	.	8.306	0.32042	0.1291:0.0:0.8709:0.0	.	462;373;373	Q66K58;F5H7K6;P0CG48	.;.;UBC_HUMAN	M	373;373;297;373;297	ENSP00000441543:L373M;ENSP00000344818:L373M;ENSP00000438394:L297M	ENSP00000344818:L373M	L	-	1	2	UBC	123963154	1.000000	0.71417	1.000000	0.80357	0.935000	0.57460	2.063000	0.41423	1.611000	0.50210	0.550000	0.68814	CTG	UBC-007	KNOWN	alternative_5_UTR|basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000400177.1	-68.116983	KEEP		-	32.236087	0.038902	17	420	---	---	---	---	1	1	246	7005	0	431	19	441	0	431	2	0	0	0	0	0	0	19	441	0	431	2	TP
SCNN1B	0	broad.mit.edu	37	16	23360038	23360038	+	Missense_Mutation	SNP	C	C	T			GBM-TCGA-02-0055-Tumor-SM-1QUD8	GBM-TCGA-02-0055-Normal-SM-1QUDW	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-02-0055-Tumor-SM-1QUD8	GBM-TCGA-02-0055-Normal-SM-1QUDW	g.chr16:23360038C>T	ENST00000343070.2	+	2	294	c.118C>T	c.(118-120)Cgc>Tgc	p.R40C	SCNN1B_ENST00000307331.5_Missense_Mutation_p.R85C|SCNN1B_ENST00000569789.1_3'UTR|SCNN1B_ENST00000568923.1_Missense_Mutation_p.R40C|SCNN1B_ENST00000568085.1_Missense_Mutation_p.R40C	NM_000336.2	NP_000327.2	P51168	SCNNB_HUMAN	sodium channel, non-voltage-gated 1, beta subunit	40		NA		NA	excretion|sensory perception of taste	apical plasma membrane	ligand-gated sodium channel activity|WW domain binding			breast(2)|endometrium(3)|kidney(2)|large_intestine(5)|liver(2)|lung(8)|ovary(3)|pancreas(1)|prostate(3)|skin(1)|stomach(1)|urinary_tract(1)	32				GBM - Glioblastoma multiforme(48;0.0465)	Amiloride(DB00594)|Triamterene(DB00384)	CGGCCCCAAGCGCATCATCTG	0.622	NA	NA					NA				NA	NA		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA		NA		0							NA						71	62	65	NA		NA	NA	16		NA											NA				23360038		2197	4300	6497	SO:0001583	missense			ENSG00000168447	HGNC:10600		Approved	uc002dln.3	NA	C5HTZ2|O60891|Q96KG2|Q9UJ32|Q9UMU5	ENST00000343070.2	37	CCDS10609.1	.	.	.	.	.	.	.	.	.	.	C	24.2	4.499684	0.85176	.	.	ENSG00000168447	ENST00000343070;ENST00000307331	T;T	0.65178	-0.14;-0.14	4.91	4.91	0.64330	.	0.077952	0.53938	D	0.000041	D	0.82527	0.5056	M	0.88640	2.97	0.80722	D	1	D	0.89917	1.0	D	0.91635	0.999	D	0.86546	0.1831	10	0.87932	D	0	-7.2594	17.0902	0.86620	0.0:1.0:0.0:0.0	.	40	P51168	SCNNB_HUMAN	C	40;85	ENSP00000345751:R40C;ENSP00000302874:R85C	ENSP00000302874:R85C	R	+	1	0	SCNN1B	23267539	1.000000	0.71417	1.000000	0.80357	0.986000	0.74619	5.745000	0.68672	2.258000	0.74832	0.561000	0.74099	CGC	SCNN1B-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000254495.2	9.621297	KEEP		+	20.005071	0.121622	9	65	---	---	---	---	1	0.3433975	2	7	0	71	10	70	0	71	2	0	0	0	0	0	0	10	70	0	71	2	TP
TP53	7157	broad.mit.edu	37	17	7578203	7578203	+	Missense_Mutation	SNP	C	C	T			GBM-TCGA-02-0055-Tumor-SM-1QUD8	GBM-TCGA-02-0055-Normal-SM-1QUDW	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Valid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-02-0055-Tumor-SM-1QUD8	GBM-TCGA-02-0055-Normal-SM-1QUDW	g.chr17:7578203C>T	ENST00000420246.2	-	6	778	c.646G>A	c.(646-648)Gtg>Atg	p.V216M	TP53_ENST00000574684.1_Intron|TP53_ENST00000455263.2_Missense_Mutation_p.V216M|TP53_ENST00000269305.4_Missense_Mutation_p.V216M|TP53_ENST00000413465.2_Missense_Mutation_p.V216M|TP53_ENST00000445888.2_Missense_Mutation_p.V216M|TP53_ENST00000359597.4_Missense_Mutation_p.V216M	NM_001126114.2|NM_001276696.1	NP_001119586.1|NP_001263625.1	P04637	P53_HUMAN	tumor protein p53	216	Interaction with AXIN1 (By similarity).|Interaction with HIPK1 (By similarity).|Required for interaction with FBXO42.	NA	V -> A (in sporadic cancers; somatic mutation).|V -> E (in sporadic cancers; somatic mutation).|V -> G (in sporadic cancers; somatic mutation).|V -> L (in sporadic cancers; somatic mutation).|V -> M (in sporadic cancers; somatic mutation).|V -> W (in a sporadic cancer; somatic mutation; requires 2 nucleotide substitutions).	NA	activation of caspase activity by cytochrome c|base-excision repair|blood coagulation|cell cycle arrest|cell differentiation|cell proliferation|cellular protein localization|cellular response to drug|cellular response to glucose starvation|cellular response to hypoxia|cellular response to ionizing radiation|cellular response to UV|determination of adult lifespan|DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest|DNA damage response, signal transduction by p53 class mediator resulting in induction of apoptosis|DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator|ER overload response|interspecies interaction between organisms|negative regulation of apoptosis|negative regulation of cell growth|negative regulation of cell proliferation|negative regulation of helicase activity|negative regulation of transcription from RNA polymerase II promoter|nucleotide-excision repair|oxidative stress-induced premature senescence|positive regulation of histone deacetylation|positive regulation of neuron apoptosis|positive regulation of peptidyl-tyrosine phosphorylation|positive regulation of reactive oxygen species metabolic process|positive regulation of thymocyte apoptosis|positive regulation of transcription from RNA polymerase II promoter|protein localization|protein tetramerization|Ras protein signal transduction|regulation of mitochondrial membrane permeability|replicative senescence|response to antibiotic|response to gamma radiation|response to X-ray	cytoplasm|cytosol|endoplasmic reticulum|insoluble fraction|mitochondrion|nuclear chromatin|nuclear matrix|nucleolus|nucleus|PML body|protein complex|replication fork	ATP binding|chaperone binding|chromatin binding|copper ion binding|damaged DNA binding|DNA strand annealing activity|histone acetyltransferase binding|p53 binding|protease binding|protein binding|protein heterodimerization activity|protein kinase binding|protein N-terminus binding|protein phosphatase 2A binding|RNA polymerase II transcription factor binding|sequence-specific DNA binding transcription factor activity|transcription regulatory region DNA binding|transcription repressor activity|ubiquitin protein ligase binding|zinc ion binding	p.V216M(61)|p.V216del(8)|p.0?(8)|p.V216L(7)|p.?(5)|p.V84M(3)|p.V123M(3)|p.V216fs*6(2)|p.H214fs*5(2)|p.V216fs*32(1)|p.V216fs*33(1)|p.S215fs*27(1)|p.S215fs*29(1)|p.V216fs*5(1)|p.V216_Y220delVVVPY(1)|p.D208_V216delDRNTFRHSV(1)|p.D208fs*1(1)|p.S215fs*31(1)|p.S215_V216insX(1)|p.T211fs*28(1)|p.D207_V216del10(1)|p.S215_V218>R(1)|p.S215_V218>M(1)		NS(16)|adrenal_gland(37)|autonomic_ganglia(16)|biliary_tract(273)|bone(108)|breast(2530)|central_nervous_system(1264)|cervix(68)|endometrium(223)|eye(24)|fallopian_tube(1)|gastrointestinal_tract_(site_indeterminate)(1)|genital_tract(16)|haematopoietic_and_lymphoid_tissue(1301)|kidney(96)|large_intestine(5124)|liver(897)|lung(2388)|meninges(5)|oesophagus(1473)|ovary(1659)|pancreas(452)|penis(10)|peritoneum(33)|pituitary(4)|placenta(1)|pleura(3)|prostate(235)|salivary_gland(43)|skin(791)|small_intestine(14)|soft_tissue(220)|stomach(1158)|testis(11)|thymus(21)|thyroid(54)|upper_aerodigestive_tract(2271)|urinary_tract(1259)|vagina(6)|vulva(79)	24185		all_cancers(10;1.01e-06)|Myeloproliferative disorder(207;0.0122)|Prostate(122;0.081)		GBM - Glioblastoma multiforme(2;1.59e-06)|READ - Rectum adenocarcinoma(115;0.174)		GGCACCACCACACTATGTCGA	0.537	NA	111	"""Mis, N, F"""		"""breast, colorectal, lung, sarcoma, adrenocortical, glioma, multiple other tumour types"""	"""breast, sarcoma, adrenocortical carcinoma, glioma, multiple other tumour types"""	NA	Other conserved DNA damage response genes	Osteosarcoma, Familial Clustering of;Li-Fraumeni syndrome;Hereditary Breast-Ovarian Cancer, non-BRCA1/2;Hereditary Adrenocortical Cancer;Endometrial Cancer, Familial Clustering of	HNSCC(1;<9.43e-08)|TCGA GBM(1;<1E-08)|TSP Lung(2;<1E-08)|TCGA Ovarian(1;<1.89e-07)|Multiple Myeloma(5;0.019)	NA	NA		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA		Pancreas(47;798 1329 9957 10801)	yes	Rec	yes	Li-Fraumeni syndrome	17	17p13	7157	tumor protein p53	NA	"""L, E, M, O"""	113	Substitution - Missense(74)|Deletion - In frame(11)|Deletion - Frameshift(8)|Whole gene deletion(8)|Unknown(5)|Insertion - Frameshift(4)|Complex - deletion inframe(2)|Insertion - In frame(1)	breast(17)|lung(14)|haematopoietic_and_lymphoid_tissue(12)|ovary(12)|upper_aerodigestive_tract(10)|large_intestine(9)|oesophagus(9)|biliary_tract(5)|central_nervous_system(5)|bone(5)|stomach(4)|liver(4)|pancreas(3)|soft_tissue(2)|urinary_tract(1)|skin(1)	GRCh37	CX952222	TP53	X	NA						123	111	115	NA		NA	NA	17		NA											NA				7578203		2203	4300	6503	SO:0001583	missense	Familial Cancer Database	Familial Osteogenic Sarcoma;LFS, SBLA syndrome (Sarcoma Breast Leukemia Adrenal cancer), incl.: Cancer with In Vitro Radioresistence, Familial, Li-Fraumeni-like s.;BRCAX;Familial Adrenocortical Carcinoma;	ENSG00000141510	HGNC:11998	NM_000546	Approved	uc002gij.3	NA	Q15086|Q15087|Q15088|Q16535|Q16807|Q16808|Q16809|Q16810|Q16811|Q16848|Q2XN98|Q3LRW1|Q3LRW2|Q3LRW3|Q3LRW4|Q3LRW5|Q86UG1|Q8J016|Q99659|Q9BTM4|Q9HAQ8|Q9NP68|Q9NPJ2|Q9NZD0|Q9UBI2|Q9UQ61	ENST00000420246.2	37	CCDS45606.1	.	.	.	.	.	.	.	.	.	.	C	28.9	4.958421	0.92726	.	.	ENSG00000141510	ENST00000413465;ENST00000359597;ENST00000269305;ENST00000455263;ENST00000420246;ENST00000445888;ENST00000396473;ENST00000545858;ENST00000509690;ENST00000514944;ENST00000414315	D;D;D;D;D;D;D;D	0.99868	-7.32;-7.32;-7.32;-7.32;-7.32;-7.32;-7.32;-7.32	5.28	5.28	0.74379	p53, DNA-binding domain (1);p53-like transcription factor, DNA-binding (1);p53/RUNT-type transcription factor, DNA-binding domain (1);	0.000000	0.85682	D	0.000000	D	0.99889	0.9947	M	0.92169	3.28	0.80722	D	1	D;D;D;D;D;D;D	0.89917	1.0;1.0;1.0;1.0;1.0;1.0;1.0	D;D;D;D;D;D;D	0.97110	1.0;1.0;0.996;1.0;1.0;1.0;1.0	D	0.96411	0.9304	10	0.87932	D	0	-12.2832	16.7921	0.85592	0.0:1.0:0.0:0.0	.	177;216;216;123;216;216;216	B4E095;P04637-2;P04637-3;E9PFT5;P04637;Q1MSW8;E7EQX7	.;.;.;.;P53_HUMAN;.;.	M	216;216;216;216;216;216;205;123;84;123;84	ENSP00000410739:V216M;ENSP00000352610:V216M;ENSP00000269305:V216M;ENSP00000398846:V216M;ENSP00000391127:V216M;ENSP00000391478:V216M;ENSP00000425104:V84M;ENSP00000423862:V123M	ENSP00000269305:V216M	V	-	1	0	TP53	7518928	1.000000	0.71417	0.978000	0.43139	0.971000	0.66376	7.775000	0.85489	2.634000	0.89283	0.563000	0.77884	GTG	TP53-005	KNOWN	NMD_exception|basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000367401.1	112.408356	KEEP		-	113.034453	0.610169	36	23	---	---	---	---	1	1	65	15	0	99	40	25	0	99	2	1	1	120	80	0	153	40	25	0	99	2	TP
ARSG	22901	broad.mit.edu	37	17	66416616	66416616	+	3'UTR	SNP	T	T	G			GBM-TCGA-02-0055-Tumor-SM-1QUD8	GBM-TCGA-02-0055-Normal-SM-1QUDW	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-02-0055-Tumor-SM-1QUD8	GBM-TCGA-02-0055-Normal-SM-1QUDW	g.chr17:66416616T>G	ENST00000448504.2	+	0	2386				WIPI1_ENST00000589459.1_5'Flank|RP11-120M18.2_ENST00000592030.1_RNA|ARSG_ENST00000452479.2_3'UTR|ARSG_ENST00000582154.1_3'UTR	NM_014960.4	NP_055775.2	Q96EG1	ARSG_HUMAN	arylsulfatase G	NA		NA		NA	sulfur compound metabolic process	endoplasmic reticulum|extracellular space|lysosome	arylsulfatase activity|metal ion binding			NS(2)|endometrium(3)|kidney(1)|large_intestine(8)|lung(8)|ovary(1)|prostate(1)|stomach(1)|urinary_tract(1)	26			BRCA - Breast invasive adenocarcinoma(8;5.34e-07)|LUSC - Lung squamous cell carcinoma(166;0.24)			AGACCAATTTTTATTCCACGA	0.438	NA	NA					NA				NA	NA		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA		NA		0							NA						106	110	109	NA		NA	NA	17		NA											NA				66416616		2203	4300	6503	SO:0001624	3_prime_UTR_variant			ENSG00000141337	HGNC:24102	NM_014960	Approved	uc002jhc.2	NA	Q6UXF2|Q9Y2K4	ENST00000448504.2	37	CCDS11676.1																																																																																			ARSG-002	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000448369.1	296.445416	KEEP		+	296.770274	0.549669	83	68	---	---	---	---	1	0.9999633	15	2	1	234	123	97	1	234	2	0	0	0	0	0	0	123	97	1	234	2	TP
PIN1	5300	broad.mit.edu	37	19	9960204	9960204	+	3'UTR	SNP	C	C	A			GBM-TCGA-02-0055-Tumor-SM-1QUD8	GBM-TCGA-02-0055-Normal-SM-1QUDW	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-02-0055-Tumor-SM-1QUD8	GBM-TCGA-02-0055-Normal-SM-1QUDW	g.chr19:9960204C>A	ENST00000247970.4	+	0	843				PIN1_ENST00000380889.6_Intron|PIN1_ENST00000588695.1_Intron|AC008752.3_ENST00000582439.1_RNA	NM_006221.3	NP_006212.1	Q13526	PIN1_HUMAN	peptidylprolyl cis/trans isomerase, NIMA-interacting 1	NA		NA		NA	cell cycle|negative regulation of cell motility|negative regulation of ERK1 and ERK2 cascade|negative regulation of transforming growth factor beta receptor signaling pathway|negative regulation of type I interferon production|positive regulation of Rho GTPase activity|positive regulation of ubiquitin-protein ligase activity|protein folding|regulation of mitosis|regulation of pathway-restricted SMAD protein phosphorylation	nucleoplasm	GTPase activating protein binding|mitogen-activated protein kinase kinase binding|peptidyl-prolyl cis-trans isomerase activity|phosphoserine binding|phosphothreonine binding			skin(3)	3						CCCGTGTCCCCCCAGGTGCTG	0.622	NA	NA					NA				NA	NA		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA		NA		0							NA						61	63	63	NA		NA	NA	19		NA											NA				9960204		876	1991	2867	SO:0001624	3_prime_UTR_variant			ENSG00000127445	HGNC:8988		Approved	uc002mml.2	NA	A8K4V9|Q53X75	ENST00000247970.4	37	CCDS12220.1																																																																																			PIN1-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000451107.1	140.515721	KEEP		+	141.056914	0.42735	50	67	---	---	---	---	1	1	243	196	2	106	52	82	2	106	20	0	0	0	0	0	0	52	82	2	106	2	TP
ASXL1	171023	broad.mit.edu	37	20	31022345	31022345	+	Silent	SNP	C	C	T			GBM-TCGA-02-0055-Tumor-SM-1QUD8	GBM-TCGA-02-0055-Normal-SM-1QUDW	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-02-0055-Tumor-SM-1QUD8	GBM-TCGA-02-0055-Normal-SM-1QUDW	g.chr20:31022345C>T	ENST00000375687.4	+	13	2254	c.1830C>T	c.(1828-1830)ggC>ggT	p.G610G	ASXL1_ENST00000306058.5_Silent_p.G605G	NM_015338.5	NP_056153.2	Q8IXJ9	ASXL1_HUMAN	additional sex combs like 1 (Drosophila)	610		NA		NA	chromatin modification|regulation of transcription, DNA-dependent|transcription, DNA-dependent	PR-DUB complex	metal ion binding|protein binding	p.Q592fs*5(1)|p.G610G(1)		NS(1)|breast(2)|central_nervous_system(3)|endometrium(2)|haematopoietic_and_lymphoid_tissue(655)|kidney(5)|large_intestine(18)|liver(1)|lung(27)|ovary(1)|prostate(3)|skin(3)|upper_aerodigestive_tract(1)	722						GTTGGACTGGCGCCAGGACCC	0.632	NA	NA	"""F, N, Mis"""		"""MDS, CMML"""		NA				NA	NA		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA				Rec	yes		20	20q11.1	171023	additional sex combs like 1	NA	L	2	Deletion - Frameshift(1)|Substitution - coding silent(1)	haematopoietic_and_lymphoid_tissue(1)|central_nervous_system(1)					NA	C		1,4405		0,1,2202	29	31	30	NA	1830	-10.8	0.5	20		30	1,8599		0,1,4299	no	coding-synonymous	ASXL1	NM_015338.5		0,2,6501	TT,TC,CC	NA	0.0116,0.0227,0.0154		610/1542	31022345	2,13004	2203	4300	6503	SO:0001819	synonymous_variant			ENSG00000171456	HGNC:18318	NM_015338	Approved	uc002wxs.3	NA	B2RP59|Q5JWS9|Q8IYY7|Q9H466|Q9NQF8|Q9UFJ0|Q9UFP8|Q9Y2I4	ENST00000375687.4	37	CCDS13201.1																																																																																			ASXL1-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000078624.2	67.725952	KEEP		+	70.437569	0.309524	26	58	---	---	---	---	1	0.9998742	15	24	0	82	30	72	0	82	2	0	0	0	0	0	0	30	72	0	82	2	TP
TPST2	8459	broad.mit.edu	37	22	26937269	26937269	+	Missense_Mutation	SNP	G	G	A			GBM-TCGA-02-0055-Tumor-SM-1QUD8	GBM-TCGA-02-0055-Normal-SM-1QUDW	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-02-0055-Tumor-SM-1QUD8	GBM-TCGA-02-0055-Normal-SM-1QUDW	g.chr22:26937269G>A	ENST00000338754.4	-	3	598	c.328C>T	c.(328-330)Cgc>Tgc	p.R110C	TPST2_ENST00000403880.1_Missense_Mutation_p.R110C|TPST2_ENST00000398110.2_Missense_Mutation_p.R110C	NM_003595.3	NP_003586.3	O60704	TPST2_HUMAN	tyrosylprotein sulfotransferase 2	110		NA		NA	peptidyl-tyrosine sulfation	endoplasmic reticulum|Golgi membrane|integral to membrane|membrane fraction	protein-tyrosine sulfotransferase activity			central_nervous_system(1)|large_intestine(1)|lung(5)	7						CAGGCCTGGCGCATGGCCAGC	0.697	NA	NA					NA				NA	NA		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA		NA		0							NA						27	25	26	NA		NA	NA	22		NA											NA				26937269		2202	4298	6500	SO:0001583	missense			ENSG00000128294	HGNC:12021	NM_003595	Approved	uc003acx.3	NA	B3KQA7|Q6FI98|Q9H0V4	ENST00000338754.4	37	CCDS13839.1	.	.	.	.	.	.	.	.	.	.	G	14.93	2.682371	0.47991	.	.	ENSG00000128294	ENST00000338754;ENST00000398110;ENST00000403880;ENST00000528868;ENST00000442495;ENST00000454778	T;T;T;T;T	0.49139	0.79;0.79;0.79;0.79;0.79	5.09	4.08	0.47627	Sulfotransferase domain (1);	0.078282	0.53938	D	0.000044	T	0.70133	0.3189	M	0.84433	2.695	0.80722	D	1	D	0.89917	1.0	D	0.85130	0.997	T	0.74873	-0.3516	10	0.66056	D	0.02	-29.5816	12.6001	0.56492	0.0803:0.0:0.9197:0.0	.	110	O60704	TPST2_HUMAN	C	110;110;110;43;110;110	ENSP00000339813:R110C;ENSP00000381180:R110C;ENSP00000385192:R110C;ENSP00000403875:R110C;ENSP00000400357:R110C	ENSP00000339813:R110C	R	-	1	0	TPST2	25267269	1.000000	0.71417	1.000000	0.80357	0.129000	0.20672	3.750000	0.55157	1.162000	0.42619	-0.192000	0.12808	CGC	TPST2-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000320820.3	67.120843	KEEP		-	69.041278	0.333333	26	52	---	---	---	---	1	1	88	162	0	64	34	68	0	64	2	0	0	0	0	0	0	34	68	0	64	2	TP
GEMIN8	54960	broad.mit.edu	37	X	14027285	14027285	+	Missense_Mutation	SNP	C	C	T			GBM-TCGA-02-0055-Tumor-SM-1QUD8	GBM-TCGA-02-0055-Normal-SM-1QUDW	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-02-0055-Tumor-SM-1QUD8	GBM-TCGA-02-0055-Normal-SM-1QUDW	g.chrX:14027285C>T	ENST00000380523.4	-	5	794	c.476G>A	c.(475-477)cGg>cAg	p.R159Q	GEMIN8_ENST00000398355.3_Missense_Mutation_p.R159Q	NM_017856.2	NP_060326.1	Q9NWZ8	GEMI8_HUMAN	gem (nuclear organelle) associated protein 8	159		NA		NA	spliceosomal snRNP assembly	Cajal body|cytoplasm|SMN complex|spliceosomal complex	protein binding			breast(1)|central_nervous_system(1)|endometrium(1)|kidney(1)|large_intestine(1)|lung(4)	9						CTGCTGCTGCCGCCCTGAGAA	0.582	NA	NA					NA				NA	NA		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA		NA		0							NA						52	45	47	NA		NA	NA	X		NA											NA				14027285		2203	4300	6503	SO:0001583	missense			ENSG00000046647	HGNC:26044	NM_017856	Approved	uc004cwd.3	NA	C4AMC4|Q2LJ66|Q6ZV27	ENST00000380523.4	37	CCDS14159.1	.	.	.	.	.	.	.	.	.	.	.	20.7	4.027505	0.75390	.	.	ENSG00000046647	ENST00000380523;ENST00000398355;ENST00000332885	T;T;T	0.46819	0.86;0.86;0.86	5.65	5.65	0.86999	.	0.171597	0.53938	D	0.000058	T	0.60919	0.2306	L	0.55213	1.73	0.36755	D	0.882968	D	0.89917	1.0	D	0.67382	0.951	T	0.69157	-0.5219	10	0.72032	D	0.01	.	11.2292	0.48901	0.0:0.9153:0.0:0.0847	.	159	Q9NWZ8	GEMI8_HUMAN	Q	159	ENSP00000369895:R159Q;ENSP00000381398:R159Q;ENSP00000369894:R159Q	ENSP00000369894:R159Q	R	-	2	0	GEMIN8	13937206	0.994000	0.37717	1.000000	0.80357	0.821000	0.46438	1.318000	0.33643	2.397000	0.81536	0.600000	0.82982	CGG	GEMIN8-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000055815.1	241.971131	KEEP		-	243.486656	0.406091	80	117	---	---	---	---	1	1	78	19	0	158	101	153	0	158	2	0	0	0	0	0	0	101	153	0	158	2	TP
